* Quipt Home Medical Corp QIPT.TO is expected to show a
rise in
quarterly revenue when it reports results on August 15.
* The Wilder Kentucky-based company is expected to report
a
63.6% increase in revenue to $60.029 million from $36.69 million
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Quipt Home Medical
Corp
is for breakeven results per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Quipt Home
Medical Corp is $10.06, above its last closing price of $5.20.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.04 0.04 -0.02 Missed -147.1
Dec. 31 2023 0.04 0.05 0.01 Missed -77.8
Sep. 30 2022 0.02 0.02 0.07 Beat 250
Jun. 30 2022 0.00 0.00 0.00 Met
Mar. 0.00 0.03 0.14 Beat 366.7
31 2022
Dec. 31 2021 -0.02 -0.01 -0.06 Missed -799.5
Sep. 30 2021 -0.03 -0.01 -0.04 Missed -220
Jun. 30 2021 0.04 0.04 0.19 Beat 418.1
This summary was machine generated August 11 at 14:15 GMT. All
figures in US dollars unless otherwise stated